Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Conditions

Alopecia Areata

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Study Site 102, Asahikawa, Japan

  • Study Site 117, Bunkyō City, Japan

  • Study Site 119, Ebina, Japan

  • Study Site 101, Hamamatsu, Japan

  • Study Site 116, Ishikawa, Japan

  • Study Site 112, Kitakyushu, Japan

  • Study Site 118, Kōtoku, Japan

  • Study Site 110, Kurashiki, Japan

  • Study Site 113, Kurume, Japan

  • Study Site 107, Kyoto, Japan

  • Study Site 106, Mitaka-shi, Japan

  • Study Site 114, Miyagi-gun, Japan

  • Study Site 104, Niigata, Japan

  • Study Site 109, Osaka, Japan

  • Study Site 108, Osaka, Japan

  • Study Site 103, Sapporo, Japan

  • Study Site 105, Shinjuku-Ku, Japan

  • Study Site 111, Ube, Japan